1. Home
  2. CYTK vs LEVI Comparison

CYTK vs LEVI Comparison

Compare CYTK & LEVI Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Cytokinetics Incorporated

CYTK

Cytokinetics Incorporated

N/A

Current Price

$59.89

Market Cap

7.6B

Sector

Health Care

ML Signal

N/A

Logo Levi Strauss & Co

LEVI

Levi Strauss & Co

N/A

Current Price

$18.18

Market Cap

9.1B

ML Signal

N/A

Company Overview

Basic Information
Metric
CYTK
LEVI
Founded
1997
1853
Country
United States
United States
Employees
N/A
N/A
Industry
Biotechnology: Pharmaceutical Preparations
Apparel
Sector
Health Care
Consumer Discretionary
Exchange
Nasdaq
Nasdaq
Market Cap
7.6B
9.1B
IPO Year
2004
2019

Fundamental Metrics

Financial Performance
Metric
CYTK
LEVI
Price
$59.89
$18.18
Analyst Decision
Strong Buy
Strong Buy
Analyst Count
18
13
Target Price
$87.56
$26.31
AVG Volume (30 Days)
1.7M
2.1M
Earning Date
05-25-2026
04-30-2026
Dividend Yield
N/A
3.06%
EPS Growth
N/A
178.85
EPS
N/A
1.45
Revenue
$13,368,000.00
$6,282,000,000.00
Revenue This Year
$9.79
$7.85
Revenue Next Year
$302.66
$4.92
P/E Ratio
N/A
$12.62
Revenue Growth
N/A
N/A
52 Week Low
$29.31
$12.17
52 Week High
$70.98
$24.82

Technical Indicators

Market Signals
Indicator
CYTK
LEVI
Relative Strength Index (RSI) 40.30 27.09
Support Level $59.25 $16.64
Resistance Level $65.93 $22.51
Average True Range (ATR) 2.65 0.62
MACD -0.32 -0.42
Stochastic Oscillator 3.98 7.55

Price Performance

Historical Comparison
CYTK
LEVI

About CYTK Cytokinetics Incorporated

Cytokinetics Inc is a late-stage biopharmaceutical company focused on discovering, developing and commercializing first-in-class muscle activators and next-in-class muscle inhibitors as potential treatments for debilitating diseases in which muscle performance is compromised and/or declining. The company develops treatments for diseases such as amyotrophic lateral sclerosis, heart failure, spinal muscular atrophy, and chronic obstructive pulmonary diseases. The treatment is based on small molecules specifically engineered to increase muscle function and contractility. The company is developing muscle-directed investigational medicines that may potentially improve the health span of people with devastating cardiovascular and neuromuscular diseases of impaired muscle function.

About LEVI Levi Strauss & Co

Levi Strauss & Co is involved in designing, marketing, and selling products that include jeans, casual and dresses pants, tops, shorts, skirts, jackets, footwear, and related accessories directly or through third parties and licensees for men, women, and children under Levi's, Dockers, Signature by Levi Strauss & Co. and Denizen brands. The company manages its business according to three regional segments: the Americas, which is the key revenue driver; Europe; and Asia.

Share on Social Networks: